Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells.

Salerno F, Engels S, van den Biggelaar M, van Alphen FPJ, Guislain A, Zhao W, Hodge DL, Bell SE, Medema JP, von Lindern M, Turner M, Young HA, Wolkers MC.

Nat Immunol. 2018 Jul 9. doi: 10.1038/s41590-018-0155-6. [Epub ahead of print]

PMID:
29988089
2.

The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages.

Verbij FC, Sorvillo N, Kaijen PHP, Hrdinova J, Peyron I, Fijnheer R, Ten Brinke A, Meijer AB, van Alphen FPJ, van den Berg TK, Graversen JJH, Moestrup SK, Voorberg J.

Blood Adv. 2017 Jan 16;1(5):293-305. doi: 10.1182/bloodadvances.2016001321. eCollection 2017 Jan 24.

3.

Glucocorticoids induce differentiation of monocytes towards macrophages that share functional and phenotypical aspects with erythroblastic island macrophages.

Heideveld E, Hampton-O'Neil LA, Cross SJ, van Alphen FPJ, van den Biggelaar M, Toye AM, van den Akker E.

Haematologica. 2018 Mar;103(3):395-405. doi: 10.3324/haematol.2017.179341. Epub 2017 Dec 28.

4.

Monitoring storage induced changes in the platelet proteome employing label free quantitative mass spectrometry.

Rijkers M, van den Eshof BL, van der Meer PF, van Alphen FPJ, de Korte D, Leebeek FWG, Meijer AB, Voorberg J, Jansen AJG.

Sci Rep. 2017 Sep 8;7(1):11045. doi: 10.1038/s41598-017-11643-w.

5.

Differences between Platelets Derived from Neonatal Cord Blood and Adult Peripheral Blood Assessed by Mass Spectrometry.

Stokhuijzen E, Koornneef JM, Nota B, van den Eshof BL, van Alphen FPJ, van den Biggelaar M, van der Zwaan C, Kuijk C, Mertens K, Fijnvandraat K, Meijer AB.

J Proteome Res. 2017 Oct 6;16(10):3567-3575. doi: 10.1021/acs.jproteome.7b00298. Epub 2017 Aug 30.

PMID:
28823163
6.

Paradigm of Biased PAR1 (Protease-Activated Receptor-1) Activation and Inhibition in Endothelial Cells Dissected by Phosphoproteomics.

van den Eshof BL, Hoogendijk AJ, Simpson PJ, van Alphen FPJ, Zanivan S, Mertens K, Meijer AB, van den Biggelaar M.

Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1891-1902. doi: 10.1161/ATVBAHA.117.309926. Epub 2017 Aug 17.

PMID:
28818855
7.

Label-free Analysis of CD8+ T Cell Subset Proteomes Supports a Progressive Differentiation Model of Human-Virus-Specific T Cells.

van Aalderen MC, van den Biggelaar M, Remmerswaal EBM, van Alphen FPJ, Meijer AB, Ten Berge IJM, van Lier RAW.

Cell Rep. 2017 May 2;19(5):1068-1079. doi: 10.1016/j.celrep.2017.04.014.

8.

Analysis of the HLA-DR peptidome from human dendritic cells reveals high affinity repertoires and nonconventional pathways of peptide generation.

Ciudad MT, Sorvillo N, van Alphen FP, Catalán D, Meijer AB, Voorberg J, Jaraquemada D.

J Leukoc Biol. 2017 Jan;101(1):15-27. doi: 10.1189/jlb.6HI0216-069R. Epub 2016 Jun 30.

PMID:
27365532
9.

von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.

Sorvillo N, Hartholt RB, Bloem E, Sedek M, ten Brinke A, van der Zwaan C, van Alphen FP, Meijer AB, Voorberg J.

Haematologica. 2016 Mar;101(3):309-18. doi: 10.3324/haematol.2015.137067. Epub 2015 Dec 3.

10.

Erythropoietic defect associated with reduced cell proliferation in mice lacking the 26S proteasome shuttling factor Rad23b.

Bergink S, Theil AF, Toussaint W, De Cuyper IM, Kulu DI, Clapes T, van der Linden R, Demmers JA, Mul EP, van Alphen FP, Marteijn JA, van Gent T, Maas A, Robin C, Philipsen S, Vermeulen W, Mitchell JR, Gutiérrez L.

Mol Cell Biol. 2013 Oct;33(19):3879-92. doi: 10.1128/MCB.05772-11. Epub 2013 Jul 29.

11.

The Rho-GEF Trio regulates a novel pro-inflammatory pathway through the transcription factor Ets2.

Van Rijssel J, Timmerman I, Van Alphen FP, Hoogenboezem M, Korchynskyi O, Geerts D, Geissler J, Reedquist KA, Niessen HW, Van Buul JD.

Biol Open. 2013 Apr 16;2(6):569-79. doi: 10.1242/bio.20134382. Print 2013 Jun 15.

12.

The Rho-guanine nucleotide exchange factor Trio controls leukocyte transendothelial migration by promoting docking structure formation.

van Rijssel J, Kroon J, Hoogenboezem M, van Alphen FP, de Jong RJ, Kostadinova E, Geerts D, Hordijk PL, van Buul JD.

Mol Biol Cell. 2012 Aug;23(15):2831-44. doi: 10.1091/mbc.E11-11-0907. Epub 2012 Jun 13.

13.

Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients.

Krijnen PA, Hahn NE, Kholová I, Baylan U, Sipkens JA, van Alphen FP, Vonk AB, Simsek S, Meischl C, Schalkwijk CG, van Buul JD, van Hinsbergh VW, Niessen HW.

Basic Res Cardiol. 2012 Jan;107(1):233. doi: 10.1007/s00395-011-0233-5. Epub 2011 Dec 14.

14.

The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging.

Maijenburg MW, Kleijer M, Vermeul K, Mul EP, van Alphen FP, van der Schoot CE, Voermans C.

Haematologica. 2012 Feb;97(2):179-83. doi: 10.3324/haematol.2011.047753. Epub 2011 Oct 11.

15.

Inside-out regulation of ICAM-1 dynamics in TNF-alpha-activated endothelium.

van Buul JD, van Rijssel J, van Alphen FP, Hoogenboezem M, Tol S, Hoeben KA, van Marle J, Mul EP, Hordijk PL.

PLoS One. 2010 Jun 28;5(6):e11336. doi: 10.1371/journal.pone.0011336.

16.

ICAM-1 clustering on endothelial cells recruits VCAM-1.

van Buul JD, van Rijssel J, van Alphen FP, van Stalborch AM, Mul EP, Hordijk PL.

J Biomed Biotechnol. 2010;2010:120328. doi: 10.1155/2010/120328. Epub 2010 Mar 15.

17.

Diabetes mellitus induces bone marrow microangiopathy.

Oikawa A, Siragusa M, Quaini F, Mangialardi G, Katare RG, Caporali A, van Buul JD, van Alphen FP, Graiani G, Spinetti G, Kraenkel N, Prezioso L, Emanueli C, Madeddu P.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):498-508. doi: 10.1161/ATVBAHA.109.200154. Epub 2009 Dec 30.

18.
19.

Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.

Quakkelaar ED, van Alphen FP, Boeser-Nunnink BD, van Nuenen AC, Pantophlet R, Schuitemaker H.

J Virol. 2007 Aug;81(16):8533-42. Epub 2007 May 23.

20.

Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro.

Quakkelaar ED, Bunnik EM, van Alphen FP, Boeser-Nunnink BD, van Nuenen AC, Schuitemaker H.

Virology. 2007 Jul 5;363(2):447-53. Epub 2007 Mar 13.

21.

T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates.

Quakkelaar ED, Beaumont T, van Nuenen AC, van Alphen FP, Boeser-Nunnink BD, van 't Wout AB, Schuitemaker H.

Virology. 2007 Mar 1;359(1):92-104. Epub 2006 Oct 18.

Supplemental Content

Loading ...
Support Center